(Q36947727)

17 August 2017

1 reference

title

Clinical care of patients with amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

17 August 2017

0 references

3

P Nigel Leigh

1 reference

17 August 2017

2

Hiroshi Mitsumoto

1 reference

17 August 2017

Aleksandar Radunović

1

1 reference

17 August 2017

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

10

1 reference

17 August 2017

913-925

1 reference

How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Amyotrophic lateral sclerosis with supranuclear ophthalmoplegia and rigidity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Sympathetic skin response abnormalities in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Skin abnormalities and autonomic involvement in the early stage of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Subtle involvement of the sympathetic nervous system in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Are amyotrophic lateral sclerosis patients cognitively normal?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Prevalence and patterns of cognitive impairment in sporadic ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Nutritional management in MND/ALS patients: an evidence based review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Management of respiration in MND/ALS patients: an evidence based review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Promoting excellence in end-of-life care in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Current management of ALS: Comparison of the ALS CARE Database and the AAN Practice Parameter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Survival of patients with amyotrophic lateral sclerosis in a population-based registry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Mimic syndromes in sporadic cases of progressive spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Assessment of disease progression in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

1 reference

7 January 2021

The ALSFRSr predicts survival time in an ALS clinic population.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

A case of amyotrophic lateral sclerosis with a very slow progression over 44 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Atypical form of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Brachial amyotrophic diplegia associated with a novel SOD1 mutation (L106P)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Juvenile type of distal and segmental muscular atrophy of upper extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Familial Juvenile Focal Amyotrophy of the Upper Extremity (Hirayama Disease)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Primary lateral sclerosis as a phenotypic manifestation of familial ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The natural history of primary lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Improving the quality of life for people with ALS: the challenge ahead

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Multidisciplinary ALS care improves quality of life in patients with ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Communicating the diagnosis of motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Current approaches to helping children cope with a parent's terminal illness.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Hypersensitivity pneumonitis possibly caused by riluzole therapy in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Neuroprotective agents for clinical trials in ALS: a systematic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Empowering the individual with ALS at the end-of-life: disease-specific advance care planning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Caregiver burden and patients' perception of being a burden in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The value of muscle exercise in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Recurrent trismus and stridor in an ALS patient: successful treatment with botulinum toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Improvement of masseter spasticity by botulinum toxin facilitates PEG placement in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Reduction of salivary flow in amyotrophic lateral sclerosis with Scopoderm TTS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

A randomized trial of botulinum toxin A for treatment of drooling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Results of radiotherapy for drooling in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The control of oral secretions in bulbar ALS/MND.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Pharmacologic Treatment of Emotional Lability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Communication strategies of people with ALS and their partners

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Patients with ALS can use sensorimotor rhythms to operate a brain-computer interface.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

A prospective study of quality of life in ALS patients treated with noninvasive ventilation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The effect of noninvasive ventilation on ALS patients and their caregivers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The management of motor neurone disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Noninvasive ventilation in ALS: indications and effect on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Non-invasive ventilation in motor neuron disease: current UK practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Non-invasive ventilation in ALS: current practice and future role.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Nocturnal pulse oximetry: a new approach to establish the appropriate time for non‐invasive ventilation in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Respiratory muscle assessment in motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

ALS patients on TPPV: totally locked-in state, neurologic findings and ethical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Outcome of ventilatory support for acute respiratory failure in motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The use of opioids and sedatives at the end of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Morphine kills the pain, not the patient

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Nutritional status is a prognostic factor for survival in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Amyotrophic Lateral Sclerosis: Enteral Nutrition Provision—Endoscopic or Radiologic Gastrostomy?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Complications and survival following radiologically and endoscopically-guided gastrostomy in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Comparison of two percutaneous radiological gastrostomy tubes in the nutritional management of ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Entristar skin-level gastrostomy tube: primary placement with radiologic guidance in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The final month of life in patients with ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The course of the terminal phase in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The ALS Patient Care Database: insights into end-of-life care in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The involvement of specialist palliative care in the care of people with motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Medicare hospice referral criteria for patients with amyotrophic lateral sclerosis: a need for improvement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

How should clinicians describe hospice to patients and families?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Lasting impact in families after death from ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Grief support for informal caregivers of patients with ALS: a national survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

The doctor's letter of condolence.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Study protocol: delayed intervention randomised controlled trial within the Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

ALS: a disease of motor neurons and their nonneuronal neighbors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

Communicating with the "locked-in" patient: because you can do it, should you?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970244-2

7 January 2021

10.1016/S1474-4422(07)70244-2

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17884681